The elevated SRSF9 expression in GBM tumor tissues was also validated at protein level using UALCAN datasets (Fig. 1C), and a stage-specific increase in SRSF9 expression correlated to advancing GBM stages according to WHO grading (Fig. 1D). Here, SRSF9 is linked to neoplasm.